Expertise in
2
conditions

Marc R. Suter

Lausanne, VD, CH 
Expertise in
2
conditions
Lausanne, VD, CH 

Overview

Marc Suter practices practicing medicine in Lausanne, Switzerland.

Mr. Suter is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Neuralgia, Chronic Pain, Acute Pain, and Ehlers-Danlos Syndrome (EDS).

He is actively involved in clinical research, co-authoring 65 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Lausanne, VD 1011, Switzerland
Other Locations
Prilly, VD, Switzerland
Aigle, VD, Switzerland
Monthey, VS, Switzerland
34, Avenue De La Gare, Chavannes, VD 1022, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
Enrollment Status: Terminated
Publish Date: June 17, 2026
Intervention Type: Drug
Study Drug: Pregabalin
Study Phase: Phase 3
A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects With Confirmed Small Fiber Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects With Confirmed Small Fiber Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
Enrollment Status: Terminated
Publish Date: May 05, 2021
Intervention Type: Drug
Study Drug: BIIB074
Study Phase: Phase 2
View 1 Less Clinical Trial

65 Total Publications

Preventing pain chronification : the key role of primary care physicians
Preventing pain chronification : the key role of primary care physicians
Journal: Revue medicale suisse
Published: June 18, 2026

Frequently Asked Questions about Marc R. Suter

Is Marc R. Suter a top-rated expert for Neuralgia?

MediFind is an objective health platform that identifies experts based on real-world data. Marc R. Suter is classified as an Distinguished expert for Neuralgia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marc R. Suter participate in research or clinical trials?

Yes. Marc R. Suter has published 65 articles and abstracts on conditions like Neuralgia. You can view a list of Marc R. Suter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Suter's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile